Get the Stockscreener App
0.0003
0.00%
0.00
Windtree Therapeutics Inc stock is traded at $0.0003, with a volume of 250.
It is up +0.00% in the last 24 hours and down -72.73% over the past month.
WINDTREE THERAPEUTICS NEW
See More
Previous Close:
$0.0003
Open:
$0.0003
24h Volume:
250
Relative Volume:
0.00
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
$-40.00M
P/E Ratio:
-0.000035
EPS:
-8.5112
Net Cash Flow:
$-15.12M
1W Performance:
+0.00%
1M Performance:
-72.73%
6M Performance:
-97.50%
1Y Performance:
-99.64%
1-Day Range:
$0.0003
$0.0003
1-Week Range:
$0.0003
$0.0003
52-Week Range:
$0.0001
$0.19
Windtree Therapeutics Inc Stock (WINT) Company Profile
Name
Windtree Therapeutics Inc
Sector
Industry
Phone
-
Address
-
Compare WINT vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WINT
Windtree Therapeutics Inc
|
0.0003 | 0 | 0 | -40.00M | -15.12M | -8.5112 |
VRTX
Vertex Pharmaceuticals Inc
|
510.72 | 130.64B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
798.17 | 80.46B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
172.94 | 57.48B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
988.20 | 61.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
365.67 | 39.20B | 5.76B | 514.49M | 1.10B | 4.4813 |
Windtree Therapeutics Inc Stock (WINT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-26-20 | Initiated | Ladenburg Thalmann | Buy |
Windtree Therapeutics Inc Stock (WINT) Latest News
Windtree Therapeutics Inc (WINT) Free Cash Flow 2024: $15.4M outflow, down 14.6% - Stock Titan
WINT stock trades quietly as Windtree Therapeutics focuses on next clinical and funding steps - ad-hoc-news.de
WINT stock gains 200 percent as Windtree Therapeutics trades near penny levels - ad-hoc-news.de
Windtree Therapeutics Stock Price Forecast. Should You Buy WINT? - StockInvest.us
Windtree Therapeutics (WINT) Stock Forecast & Analyst Ratings - Moomoo
Enterprise value to revenue forward of Windtree Therapeutics, Inc. – OTC:WINT - TradingView
Price to earnings forward of Windtree Therapeutics, Inc. – OTC:WINT - TradingView
Windtree Therapeutics sells Seismic IP and related assets to Seismic Operations for USD 150,000 - Bitget
Windtree Therapeutics Sells Cardiovascular Portfolio, Retains Upside - TipRanks
Windtree Sells Cardiovascular Assets to Seismic; Keeps 20% Upside, $700k on $10M Financing - TradingView
Windtree Therapeutics, Inc. Actuals & Estimates (OTC:WINT) - TradingView
Windtree Therapeutics Inc (WINT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Windtree Therapeutics Inc (WINT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Windtree Therapeutics Inc (WINT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Windtree Therapeutics Inc (WINT) Institutional Confidence - TradingKey
Windtree Therapeutics Inc (WINT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Windtree Therapeutics Inc (WINT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Windtree Therapeutics Inc (WINT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Windtree Therapeutics Inc (WINT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Windtree Therapeutics Inc (WINT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Windtree Therapeutics stock (US97382D2049): what the delisting means for investors - AD HOC NEWS
TradingKey - TradingKey
WINT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
WINT | WINDTREE THERAPEUTICS NEW Insider Trading - Quiver Quantitative
Drug developer emerges in Durham with former Windtree assets - The Business Journals
Earnings Beat: Is Windtree Therapeutics Inc a strong growth stock2026 AllTime Highs & Community Trade Idea Sharing Platform - baoquankhu1.vn
Windtree Therapeutics (WINT) Eps Diluted (TTM) - Zacks Investment Research
Windtree Therapeutics Delays Filing of Annual Report - TipRanks
What analysts say about Windtree Therapeutics Inc stockPortfolio Profit Report & Daily Stock Momentum Reports - baoquankhu1.vn
Windtree (WINT) delays 2025 Form 10-K, expects to file by April 15, 2026 - Stock Titan
Windtree Therapeutics Stock: Clinical-Stage Biotech Focused on Respiratory Therapies Amid Volatile T - AD HOC NEWS
Windtree Therapeutics (WINT) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Windtree Therapeutics, Inc. (WINT) stock price, news, quote and history - Yahoo Finance Singapore
Market Moves: What analysts say about Windtree Therapeutics Inc stockTreasury Yields & Real-Time Stock Movement Alerts - baoquankhu1.vn
Windtree Therapeutics Secures $520 Million in Equity Agreements to Expand BNB Cryptocurrency Holdings - MSN
Can Windtree Therapeutics Inc sustain earnings growth2026 Short Interest & Precise Trade Entry Recommendations - baoquankhu1.vn
Earnings Beat: Is Windtree Therapeutics Inc a defensive stock2026 Spike Watch & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Evofem (NASDAQ: EVFM) ends Windtree PHEXXI supply deal without termination fees - Stock Titan
LYRA Stock Price and Chart — OTC:LYRA - tradingview.com
CommLoan Achieves Nationwide Regulatory Approval Across All 50 States – Company Announcement - Financial Times
AI mortgage marketplace CommLoan goes nationwide, pursues reverse merger - Stock Titan
Windtree Therapeutics, Inc.Common Stock (NQ: WINT - The Chronicle-Journal
Scottsdale fintech CommLoan plans reverse merger - bizjournals.com
Windtree Showcases Promising Istaroxime Data for Cardiogenic Shock at Major Conference - MSN
WINT Soars, DXCM Plunges, AVXL Gains: Retail Investors' Focus Premarket - Stocktwits
Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates - GlobeNewswire
Warrington’s Windtree Therapeutics Agrees to Buy Fintech Platform CommLoan - BUCKSCO.Today
Windtree Therapeutics Announces It Has Signed a Letter of - GlobeNewswire
Windtree Therapeutics issues $857,143 in convertible notes linked to CommLoan deal - Investing.com
Warrington’s Windtree Therapeutics Calls Off Acquisition of Titan Environmental Services - BUCKSCO.Today
Windtree Therapeutics Inc (WINT) Debt 2024 - Stock Titan
Windtree Therapeutics Inc Stock (WINT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
1.96%
Cap:
|
Volume (24h):